Correlates of cervical mucosal antibodies to human papillomavirus 16: Results from a case control study

Gynecologic Oncology

Volumn 99, Issue 3 SUPPL., 2005, Pages

  Bierl, Cynthia ^a   Karem, Kevin ^a   Poon, Alysia C ^a   Swan, David ^a   Tortolero Luna, Guillermo ^b,c   Follen, Michele ^b   Wideroff, Louise ^d   Unger, Elizabeth R ^a   Reeves, William C ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; VIRUS ANTIBODY; VIRUS DNA;

ANTIBODY RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; UTERINE CERVIX MUCOSA; VIRUS DETECTION; VIRUS INFECTION; VIRUS PARTICLE;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MIDDLE AGED; MUCOUS MEMBRANE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 28844445641     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.07.100     Document Type: Conference Paper

References (16)

1. J.J. Carter, L.A. Koutsky, and J.P. Hughes Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection J. Infect Dis. 18 2000 1911 1919
2. J. Konya, and J. Dillner Immunity to oncogenic human papillomaviruses Adv. Cancer Res. 82 2001 205 238
3. L.A. Koutsky, K.A. Ault, and C.M. Wheeler A controlled trial of a human papillomavirus type 16 vaccine N. Engl. J. Med. 347 2002 1645 1651
4. G.Y. Ho, Y. Studentsov, and C.B. Hall Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles J. Infect Dis. 186 6 2002 737 742
5. G. Tortolero-Luna, M.F. Mitchell, D.C. Swan, R.A. Tucker, L. Wideroff, and J.P. Icenogle A case-control study of human papillomavirus and cervical squamous intraepithelial lesions (SIL) in Harris County, Texas: differences among racial/ethnic groups Cad. Saude Publica 14 Suppl. 3 1998 149 159
6. D.C. Swan, R.A. Tucker, and G. Tortolero-Luna Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type J. Clin. Microbiol. 37 1999 1030 1034
7. K.L. Karem, A.C. Poon, C. Bierl, R. Nisenbaum, and E. Unger Optimization of a human papillomavirus-specific enzyme-linked immunosorbent assay Clin. Diagn. Lab. Immunol. 9 2002 577 582
8. K.M. Stone, K.L. Karem, and M.R. Sternberg Seroprevalence of human papillomavirus type 16 (HPV-16) infection in the United States J. Infect Dis. 186 2002 1396 1402
9. M.E. Hagensee, L.A. Koutsky, and S.K. Lee Detection of cervical antibodies to human papillomavirus type 16 (HPV-16) capsid antigens in relation to detection of HPV-16 DNA and cervical lesions J. Infect Dis. 181 2000 1234 1239
10. H.H. Nguyen, T.R. Broker, L.T. Chow, R.D. Alvarez, H.L. Vu, and J. Andrasi Immune responses to human papillomavirus in genital tract of women with cervical cancer Gynecol. Oncol. 96 2005 452 461
11. M.Y. Tjiong, J. ter Schegget, S.P. Tjong-A-Hung, T.A. Out, N. van der Vange, and M.P.M. Burger IgG antibodies against human papillomavirus type 16 E7 proteins in cervicovaginal washing fluid from patients with cervical neoplasia Int. J. Gynecol. Cancer 10 4 2000 296 304
12. K. Heim, A. Widschwendter, H. Szedenik, A. Geier, N.D. Christensen, and A. Bergant Specific serologic response to genital human papillomavirus types in patients with vulvar precancerous and cancerous lesions Am. J. Obstet. Gynecol. 92 2005 1073 1083
13. D. Nardelli-Haefliger, F. Lurati, D. Wirthner, F. Spertini, J.T. Schiller, and D.R. Lowy Immunes responses induced by lower airway mucosal immunization with a human papillomavirus type 16 virus-like particles Vaccine 23 2005 3634 3641
14. L. Rocha-Zavaleta, A.L. Pereira-Suarez, G. Yescas, R.M. Cruz-Mimiaga, A. Garcia-Carranca, and F. Cruz-Talonia Mucosal IgG and IgA responses to human papillomavirus type 16 capsid proteins in HPV16-infected women without visible pathology Viral Immunol. 16 2003 159 168
15. Z. Wang, O. Hansson, and Forslund Cervical mucus antibodies against human papillomavirus type 16, 18, and 33 capsids in relation to the presence of viral DNA J. Clin. Microbiol. 34 1996 3056 3062
16. T. Sasagawa, R.C. Rose, K.K. Azar, A. Sakai, and M. Inoue Mucosal Immunoglobulin-A and -G responses to oncogenic human papilloma virus capsids Int. J. Cancer 104 2003 328 335